0001062993-24-007048.txt : 20240325 0001062993-24-007048.hdr.sgml : 20240325 20240325161106 ACCESSION NUMBER: 0001062993-24-007048 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240325 DATE AS OF CHANGE: 20240325 EFFECTIVENESS DATE: 20240325 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NurExone Biologic Inc. CENTRAL INDEX KEY: 0001995074 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: A0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-508546 FILM NUMBER: 24779322 BUSINESS ADDRESS: STREET 1: 9 MEZADA STREET STREET 2: BSR 3 TOWER, 30 FLOOR CITY: BNEI-BRAK STATE: L3 ZIP: 5120109 BUSINESS PHONE: 972 52-4803034 MAIL ADDRESS: STREET 1: 9 MEZADA STREET STREET 2: BSR 3 TOWER, 30 FLOOR CITY: BNEI-BRAK STATE: L3 ZIP: 5120109 D 1 primary_doc.xml X0708 D LIVE 0001995074 NurExone Biologic Inc. 9 MEZADA STREET BSR 3 TOWER, 30 FLOOR BNEI-BRAK L3 ISRAEL 5120109 972 52-4803034 ALBERTA, CANADA None None Corporation true Lior Shaltiel 9 Mezada Street BSR 3 Tower 30th Floor Bnei-Brak L3 ISRAEL 5120109 Executive Officer Director Eran Ovadya 9 Mezada Street BSR 3 Tower 30th Floor Bnei-Brak L3 ISRAEL 5120109 Executive Officer Yoram Drucker 9 Mezada Street BSR 3 Tower 30th Floor Bnei-Brak L3 ISRAEL 5120109 Executive Officer Oded Orgil 9 Mezada Street BSR 3 Tower 30th Floor Bnei-Brak L3 ISRAEL 5120109 Director James Richardson 9 Mezada Street BSR 3 Tower 30th Floor Bnei-Brak L3 ISRAEL 5120109 Director Biotechnology Decline to Disclose 06b false 2024-03-22 false true true true Common Shares issued pursuant to a warrant exercise at a price of CAD$0.38 per Common Share. false 0 42634 42634 0 Common Shares issued pursuant to a warrant exercise at a price of CAD$0.38 per Common Share. US. dollar amounts based on the Bank of Canada exchange rate reported on March 22, 2024. CAD$1.00 = USD$0.7357. false 1 0 0 0 false NurExone Biologic Inc. /s/ Eran Ovadya Eran Ovadya Chief Financial Officer 2024-03-25